NCT05302804

Brief Summary

The purpose of this study is to examine the human thermoregulatory impact of applying a commercially available menthol gel (BioFreeze) to the skin prior to moderate intensity walking under heated conditions. Experimental Visits will consist of 30 min of treadmill walking at a moderate pace (3.5 mph, 5% grade) under hot conditions (38°C, 60%RH) and will be randomized and counterbalanced for BioFreeze or a hypoallergenic gel (control) application. Gels will be applied to areas commonly exposed during outdoor activity in warm conditions (shoulder to wrist, mid thigh to ankle). Accordingly, participants will wear shorts and a tank top shirt during exercise. Core temperature, skin temperature, galvanic skin response, laser doppler blood flow, and heart rate will be continuously recorded throughout the exercise bout via an integrated analog to digital converter. Sweat will be collected during exercise using commercially available absorbent patches. Thermal sensation will be assessed throughout exercise via the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) thermal sensation likert scale (cold to hot). Lastly, nude body weight will be recorded pre and post exercise for sweat rate determination. The BioFreeze and control trials will be separated by a 7-14 day washout period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started May 2022

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 17, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 31, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

April 24, 2024

Completed
Last Updated

April 24, 2024

Status Verified

March 1, 2024

Enrollment Period

5 months

First QC Date

March 17, 2022

Results QC Date

December 13, 2023

Last Update Submit

March 29, 2024

Conditions

Keywords

heat exposurementholexercise

Outcome Measures

Primary Outcomes (9)

  • Skin Blood Flow

    Laser Doppler measurement of skin blood flow

    10 minutes into exercise bout

  • Skin Blood Flow

    Laser Doppler measurement of skin blood flow

    30 minutes into exercise bout

  • Galvanic Skin Response

    measurement of skin conductance

    Time to 40 micro-siemens

  • Sweat Composition

    Sodium concentrations in collected sweat

    final 10 minutes of exercise bout

  • Sweat Rate

    Difference in Nude body weight from pre to post exercise is assumed to be the amount of weight lost via sweat. This value is then expressed as liters of sweat lost per hour if the intervention was to last 1 hr.

    pre to post exercise, approximately 30 minutes

  • Thermal Perception

    scale of thermal comfort developed by the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE). The ASHRAE is a 7-point scale to asses thermal sensation, which consists of seven verbal anchors: "cold (-3)", "cool (-2)", "slightly cool (-1)", "neutral (0)", "slightly warm (1)", "warm (2)", and "hot (3)". The score is reported as the value in "()"

    throughout the 30 minute exercise bout

  • Average Skin Temperature

    average measurements from chest, forearm, and calf thermistors

    after 30 minutes of exercise

  • Core Temperature

    measured with rectal thermistor

    after 30min exercise

  • Sweat Potassium Concentration

    this is a measure of the amount of potassium in the sweat

    final 10 minutes of the exercise bout

Secondary Outcomes (2)

  • % Body Fat

    preliminary testing before beginning the study

  • Skin Surface Area

    preliminary testing completed prior to the study procedures

Study Arms (2)

Menthol Gel first, then hypoallergenic gel

EXPERIMENTAL

Participants randomized to receive menthol gel first then hypoallergenic gel after 7 day washout. Gel is applied to the skin (arm and thigh). Participants walk on a treadmill for 30 minutes (3.5 mph at 5% grade) in 38°C and 60% relative humidity.

Drug: Menthol GelDrug: Control Gel

Hypoallergenic Gel first, then menthol

EXPERIMENTAL

Participants randomized to receive hypoallergenic gel first then menthol gel after 7 day washout. Gel is applied to the skin (arm and thigh). Participants walk on a treadmill for 30 minutes (3.5 mph at 5% grade) in 38°C and 60% relative humidity.

Drug: Menthol GelDrug: Control Gel

Interventions

5% menthol gel applied from shoulder to wrist and mid thigh to ankle, 30 minute treadmill walk (3.5 mph at 5% grade at 38°C, 60% relative humidity)

Also known as: BioFreeze
Hypoallergenic Gel first, then mentholMenthol Gel first, then hypoallergenic gel

Hypoallergenic gel applied from shoulder to wrist and mid thigh to ankle, 30 minute treadmill walk (3.5 mph at 5% grade at 38°C, 60% relative humidity)

Also known as: placebo
Hypoallergenic Gel first, then mentholMenthol Gel first, then hypoallergenic gel

Eligibility Criteria

Age19 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years of age
  • cleared for physical activity via the 2022 physical activity readiness questionnaire (PARQ)
  • no self-reported adverse reactions to menthol based gels

You may not qualify if:

  • outside 19-45 years of age
  • not cleared for physical activity via the 2022 physical activity readiness questionnaire (PARQ)
  • self-report or signs of sensitivity to menthol gels
  • pregnant
  • breast feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nebraska at Omaha

Omaha, Nebraska, 68182, United States

Location

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Results Point of Contact

Title
Dustin Slivka
Organization
University of Montana

Study Officials

  • Dustin R Slivka, PhD

    University of Montana

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Each Subject acts as their own control in a repeated measures design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 17, 2022

First Posted

March 31, 2022

Study Start

May 1, 2022

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

April 24, 2024

Results First Posted

April 24, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations